cost-effective
sleep apnea monitoring,
from home.
Shortening the path to treatment.
Over 1 billion people worldwide suffer from undiagnosed and untreated sleep apnea. The condition severely impacts the health and quality of life of patients and those around them. The demand for diagnosis is clear—but today’s hospital infrastructure is too limited to meet it.
Want to stay up to date on the release of our monitoring solution? → Get in touch.
The Challenge: Capacity and Cost
Hospitals and sleep clinics face growing demand, long waiting lists, and rising costs. While home monitoring was introduced to expand diagnostic capacity, most solutions remain too complex for patients to use independently, often requiring training or assistance from a technician to set up. As a result, around 80% of sleep apnea cases remain undiagnosed, leaving millions of patients without access to treatment.
LTSM Systems: Lower Cost and a Shorter Path to Treatment
LTSM Systems is developing a reliable, easy-to-use home sleep apnea monitoring solution designed to deliver level 3 standard diagnostic data in home settings. By simplifying home monitoring while ensuring reliable measurements, the solution enables clinics to increase patient turnover, shorten waiting lists and time to treatment, and reduce diagnostic costs.
Capturing Large and Rapidly Growing markets
The global sleep apnea home monitoring device market is experiencing steady growth and a clear shift toward patient-centric diagnostics. Valued at approximately $2 billion in 2023, the market is expanding at around 6% annually, driven by advances in wearable technology, remote patient monitoring, and improved reimbursement policies.
interested in our monitoring solution? → Stay up to date on the release.
All Crucial Sleep Apnea Parameters, Measured at Home
Our solution captures the key physiological signals required for sleep apnea diagnosis—airflow, blood oxygen saturation (SpO₂), respiratory effort, and heart rate—delivering level 3 reliable standard data.
A Joint Effort with Our Flemish Partners
LTSM Systems is advancing through its R&D phase and preparing the regulatory pathway for its home sleep apnea monitoring solution in both the EU and US medical device markets.Together with leading Flemish partners UZA (Antwerp University Hospital) and Voxdale, LTSM Systems is benchmarking its device against gold-standard polysomnography, positioning its technology as a leading solution for home sleep apnea monitoring.
Want to be part of this story?
→ Start a conversation with us.
About
LTSM Systems is building a strong consortium of clinical, engineering, and innovation partners, supported by organizations such as FIT, VLAIO, and BIOVIA, to accelerate validation and market entry.
LTSM Systems’s founder brings over 10 years of research experience at Europe’s leading research center in microelectronics and ICT systems, providing the strong technical foundation to develop clinically reliable medical technology together with its partners.
Want to stay up to date?
Want to be part of this story?
→Let’s talk.
Dunden
Lange Gasthuisstraat 29-32
2000 Antwerp (Belgium)
info@ltsm-systems.be
